Gyre Therapeutics (GYRE) Receivables (2012 - 2026)
Gyre Therapeutics (GYRE) posted Receivables of $28.25 million for Q2 2026, up 11.4% from $25.36 million a year earlier and up 5.4% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Receivables (2012 - 2026) Analysis & Trends
At the end of FY2025, Gyre Therapeutics' Receivables came in at $36.95 million, up 27.7% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of 62.0% (FY2020 to FY2025).
- In prior years, Gyre Therapeutics' Receivables was $28.92 million in FY2024 (+71.6%), $16.85 million in FY2023 (-1.7%), $17.14 million in FY2022 (+842.6%) and $1.82 million in FY2021 (-45.1%).
- Quarterly Receivables has run from a low of $564,000 in Q1 2022 to a high of $36.92 million in Q4 2025 over five years.
- On a year-over-year basis, Receivables has increased in each of the last seven quarters, with growth averaging 31.5% over the last seven quarters.
- The strongest year-over-year quarter for Receivables in the past five years was Q4 2022, with growth of 842.6%; the weakest was Q4 2021, with a decline of 45.1%.
- According to Business Quant data, Receivables for the three prior quarters was $26.81 million (Q1 2026), $36.92 million (Q4 2025) and $26.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | 28.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.25 Mn |
| Mar 31, 2026 | 26.81 Mn |
| Dec 31, 2025 | 36.92 Mn |
| Sep 30, 2025 | 26.80 Mn |
| Jun 30, 2025 | 25.36 Mn |
| Mar 31, 2025 | 22.52 Mn |
| Dec 31, 2024 | 28.92 Mn |
| Sep 30, 2024 | 20.79 Mn |
| Jun 30, 2024 | 19.92 Mn |
| Mar 31, 2024 | 16.76 Mn |
| Dec 31, 2023 | 16.85 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 17.14 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 564,000.00 |
| Dec 31, 2021 | 1.82 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.97 Mn |
| Mar 31, 2021 | 1.01 Mn |
API Access
Gyre Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();